Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANSOPRAZOLE Cause Tubulointerstitial nephritis? 3,860 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 3,860 reports of Tubulointerstitial nephritis have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 6.3% of all adverse event reports for LANSOPRAZOLE.

3,860
Reports of Tubulointerstitial nephritis with LANSOPRAZOLE
6.3%
of all LANSOPRAZOLE reports
569
Deaths
504
Hospitalizations

How Dangerous Is Tubulointerstitial nephritis From LANSOPRAZOLE?

Of the 3,860 reports, 569 (14.7%) resulted in death, 504 (13.1%) required hospitalization, and 28 (0.7%) were considered life-threatening.

Is Tubulointerstitial nephritis Listed in the Official Label?

Yes, Tubulointerstitial nephritis is listed as a known adverse reaction in the official FDA drug label for LANSOPRAZOLE.

What Other Side Effects Does LANSOPRAZOLE Cause?

Chronic kidney disease (32,517) Acute kidney injury (16,359) Renal failure (12,509) End stage renal disease (9,734) Renal injury (9,383) Death (2,517) Gastrooesophageal reflux disease (2,482) Off label use (2,183) Nephrogenic anaemia (2,162) Renal impairment (2,063)

What Other Drugs Cause Tubulointerstitial nephritis?

OMEPRAZOLE (4,809) ESOMEPRAZOLE (4,024) PANTOPRAZOLE (3,590) DEXLANSOPRAZOLE (2,177) RABEPRAZOLE (1,125) PEMBROLIZUMAB (860) IBUPROFEN (844) VANCOMYCIN (523) TACROLIMUS (486) NIVOLUMAB (467)

Which LANSOPRAZOLE Alternatives Have Lower Tubulointerstitial nephritis Risk?

LANSOPRAZOLE vs LANTHANUM LANSOPRAZOLE vs LANTUS LANSOPRAZOLE vs LANTUS SOLOSTAR LANSOPRAZOLE vs LAPATINIB LANSOPRAZOLE vs LAPATINIB DITOSYLATE

Related Pages

LANSOPRAZOLE Full Profile All Tubulointerstitial nephritis Reports All Drugs Causing Tubulointerstitial nephritis LANSOPRAZOLE Demographics